학술논문

坚持他汀中国剂量主旋律 / Sticking to Use Statin Dose Treatment as Main Rhyme
Document Type
Academic Journal
Source
医学与哲学 / Medicine & Philosophy. 38(18):9-11
Subject
血脂异常
他汀剂量
指南
abnormal blood lipids
statin dose
guideline
Language
Chinese
ISSN
1002-0772
Abstract
本文在对2016年中国成人血脂指南的核心要点述评基础上,针对欧洲血脂指南低密度脂蛋白胆固醇(LDL-C)目标值中的问题,结合中国临床实际和循证研究证据,强调中、小剂量他汀是我国大多数血脂异常患者降脂达标策略,本文明确指出对推荐使用中、小他汀类药物来防治中国的动脉粥样硬化性心血管疾病(ASCVD)患者无可争议.我们没有理由用大剂量他汀治疗中国的患者,更不应该对急性冠状动脉综合征(ACS)和经皮冠状动脉介入术(PCI)的患者突击使用阿托伐他汀80mg的序贯疗法.呼吁广大的临床医生要在落实推广中国血脂指南的工作中,用最美的音符共同奏响降脂达标坚持他汀中国剂量的主旋律.
Based on the main points of Chinese adult dyslipidemia prevention guide in 2016,according to the problem in the LDL-C value on the European guidelines,this paper emphasizes that medium and small dose statin is the main lipidlowering strategy of China's most patients with dyslipidemia,combining with China clinical practice and evidence-based research evidence.This paper refers that medium and small dose statin medicine is very important for treating Chinese ASCVD patients,at the same time,we do not need to use mass dose statin medicine to treat patients.So we should not use 80mg atorvastatin treatment for ACS and PCI patients.This paper appeal clinical doctors to popularize Chinese dyslipidemia prevention guide so that we can make use of statin dose as a main treatment method,achieving the goal of lower blood lipids.